Gene · 4928
Papers2,783
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,783
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HIV-1 capsid shape, orientation, and entropic elasticity regulate translocation into the nuclear pore complex. | Proc Natl Acad Sci U S A | 2024 | 38241438 | PubTator, text mining | PubMed |
| Sculpting nuclear envelope identity from the endoplasmic reticulum during the cell cycle. | Nucleus | 2024 | 38238284 | PubTator, text mining | PubMed |
| Quantitative comparison of nuclear transport inhibition by SARS coronavirus ORF6 reveals the importance of oligomerization. | Proc Natl Acad Sci U S A | 2024 | 38236733 | PubTator, text mining | PubMed |
| RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9. | Genome Biol | 2024 | 38216972 | PubTator, text mining | PubMed |
| The role of genetic factors in pediatric myelodysplastic syndromes with different outcomes. | BMC Pediatr | 2024 | 38191334 | PubTator, text mining | PubMed |
| Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromes. | Ther Adv Hematol | 2024 | 38186638 | PubTator, text mining | PubMed |
| Nuclear pore pathology underlying multisystem proteinopathy type 3-related inclusion body myopathy. | Ann Clin Transl Neurol | 2024 | 38158701 | PubTator, text mining | PubMed |
| Circ-NUP98 Promotes Lung Adenocarcinoma Development Through Regulating CBX1 by miR-188-3p. | Biochem Genet | 2024 | 38129720 | PubTator, text mining | PubMed |
| Defining the Clinicoradiologic Syndrome of SARS-CoV-2 Acute Necrotizing Encephalopathy: A Systematic Review and 3 New Pediatric Cases | Neurol Neuroimmunol Neuroinflamm | 2024 | 38086061 | PubTator, text mining | PubMed |
| HIV-1 capsid and viral DNA integration. | mBio | 2024 | 38085100 | PubTator, text mining | PubMed |
| Clinical whole-genome sequencing and FISH identify two different fusion partners for NUP98 in a patient with acute myeloid leukemia: A case report. | Cancer Genet | 2024 | 38056049 | PubTator, text mining | PubMed |
| Test Then Erase? Current Status and Future Opportunities for Measurable Residual Disease Testing in Acute Myeloid Leukemia. | Acta Haematol | 2024 | 38035547 | PubTator, text mining | PubMed |
| The future of HOXA- expressing leukemias: Menin inhibitor response and resistance. | Curr Opin Hematol | 2024 | 38010951 | PubTator, text mining | PubMed |
| Acute myeloid leukemias with UBTF tandem duplications are sensitive to menin inhibitors. | Blood | 2024 | 37890156 | PubTator, text mining | PubMed |
| CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216. | Blood Adv | 2024 | 37729615 | PubTator, text mining | PubMed |
| NUP98 rearrangements in AML: molecular mechanisms and clinical implications. | Onco (Basel) | 2023 | 42164049 | PubTator, text mining | PubMed |
| Chromatin 3D structure, phase separation and disease. | Life Med | 2023 | 39872108 | PubTator, text mining | PubMed |
| Identification of a Musashi2 translocation as a novel oncogene in myeloid leukemia. | bioRxiv | 2023 | 38234720 | PubTator, text mining | PubMed |
| Synergistic Sensitization of High-Grade Serous Ovarian Cancer Cells Lacking Caspase-8 Expression to Chemotherapeutics Using Combinations of Small-Molecule BRD4 and CDK9 Inhibitors. | Cancers (Basel) | 2023 | 38201534 | PubTator, text mining | PubMed |
| The PedAL/EuPAL Project: A Global Initiative to Address the Unmet Medical Needs of Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia. | Cancers (Basel) | 2023 | 38201506 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4928/papers?page=11